Literature DB >> 20943986

Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice.

Inês Antunes1, George Kassiotis.   

Abstract

The viral infection of higher vertebrates elicits potent innate and adaptive host immunity. However, an excessive or inappropriate immune response also may lead to host pathology that often is more severe than the direct effects of viral replication. Therefore, several mechanisms exist that regulate the magnitude and class of the immune response. Here, we have examined the potential involvement of regulatory T (Treg) cells in limiting pathology induced by influenza A virus (IAV) infection. Using lymphocyte-deficient mice as hosts, we showed that Treg cell reconstitution resulted in a significant delay in weight loss and prolonged survival following infection. The adoptively transferred Treg cells did not affect the high rate of IAV replication in the lungs of lymphocyte-deficient hosts, and therefore their disease-ameliorating effect was mediated through the suppression of innate immune pathology. Mechanistically, Treg cells reduced the accumulation and altered the distribution of monocytes/macrophages in the lungs of IAV-infected hosts. This reduction in lung monocytosis was associated with a specific delay in monocyte chemotactic protein-2 (MCP-2) induction in the infected lungs. Nevertheless, Treg cells failed to prevent the eventual development of severe disease in lymphocyte-deficient hosts, which likely was caused by the ongoing IAV replication. Indeed, using T-cell-deficient mice, which mounted a T-cell-independent B cell response to IAV, we further showed that the combination of virus-neutralizing antibodies and transferred Treg cells led to the complete prevention of clinical disease following IAV infection. Taken together, these results suggested that innate immune pathology and virus-induced pathology are the two main contributors to pathogenesis during IAV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943986      PMCID: PMC3004299          DOI: 10.1128/JVI.01559-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Synergistic induction of MCP-1 and -2 by IL-1beta and interferons in fibroblasts and epithelial cells.

Authors:  S Struyf; E Van Collie; L Paemen; W Put; J P Lenaerts; P Proost; G Opdenakker; J Van Damme
Journal:  J Leukoc Biol       Date:  1998-03       Impact factor: 4.962

Review 2.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

3.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.

Authors:  Yuri P Rubtsov; Jeffrey P Rasmussen; Emil Y Chi; Jason Fontenot; Luca Castelli; Xin Ye; Piper Treuting; Lisa Siewe; Axel Roers; William R Henderson; Werner Muller; Alexander Y Rudensky
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

Review 4.  The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity.

Authors:  Gerd Müller; Uta E Höpken; Martin Lipp
Journal:  Immunol Rev       Date:  2003-10       Impact factor: 12.988

Review 5.  The pathology of influenza virus infections.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

6.  Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus.

Authors:  Carole R Baskin; Helle Bielefeldt-Ohmann; Terrence M Tumpey; Patrick J Sabourin; James P Long; Adolfo García-Sastre; Airn-E Tolnay; Randy Albrecht; John A Pyles; Pam H Olson; Lauri D Aicher; Elizabeth R Rosenzweig; Kaja Murali-Krishna; Edward A Clark; Mark S Kotur; Jamie L Fornek; Sean Proll; Robert E Palermo; Carol L Sabourin; Michael G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

Review 7.  Mechanisms of foxp3+ T regulatory cell-mediated suppression.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

8.  In vivo sites and cellular mechanisms of T reg cell-mediated suppression.

Authors:  Alexander Y Rudensky; Daniel J Campbell
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

9.  Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model.

Authors:  D Moskophidis; D Kioussis
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

10.  CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.

Authors:  Kevin J Maloy; Laurence Salaun; Rachel Cahill; Gordon Dougan; Nigel J Saunders; Fiona Powrie
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  34 in total

1.  Activation of the aryl hydrocarbon receptor during development enhances the pulmonary CD4+ T-cell response to viral infection.

Authors:  Lisbeth A Boule; Bethany Winans; Kris Lambert; Beth A Vorderstrasse; David J Topham; Martin S Pavelka; B Paige Lawrence
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-12       Impact factor: 5.464

Review 2.  T cell responses during influenza infection: getting and keeping control.

Authors:  Taeg S Kim; Jie Sun; Thomas J Braciale
Journal:  Trends Immunol       Date:  2011-03-23       Impact factor: 16.687

Review 3.  The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon Infection.

Authors:  Laura E Richert-Spuhler; Jennifer M Lund
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-18       Impact factor: 3.622

Review 4.  New insights into the aryl hydrocarbon receptor as a modulator of host responses to infection.

Authors:  B Paige Lawrence; Beth A Vorderstrasse
Journal:  Semin Immunopathol       Date:  2013-08-21       Impact factor: 9.623

Review 5.  T cell-mediated host immune defenses in the lung.

Authors:  Kong Chen; Jay K Kolls
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

6.  Dendritic cell NLRC4 regulates influenza A virus-specific CD4 T cell responses through FasL expression.

Authors:  Emma E Hornick; Jargalsaikhan Dagvadorj; Zeb R Zacharias; Ann M Miller; Ryan A Langlois; Peter Chen; Kevin L Legge; Gail A Bishop; Fayyaz S Sutterwala; Suzanne L Cassel
Journal:  J Clin Invest       Date:  2019-04-30       Impact factor: 14.808

Review 7.  The Aryl Hydrocarbon Receptor as a Modulator of Anti-viral Immunity.

Authors:  Maria Florencia Torti; Federico Giovannoni; Francisco Javier Quintana; Cybele Carina García
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

8.  An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients.

Authors:  Adrian Egli; Moacyr Silva; Daire O'Shea; Leticia E Wilson; Aliyah Baluch; Luiz F Lisboa; Luis G Hidalgo; Deepali Kumar; Atul Humar
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

9.  A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus.

Authors:  Jun Dai; Decui Pei; Baoning Wang; Yu Kuang; Laifeng Ren; Kang Cao; Bin Zuo; Jingjing Shao; Sha Li; Zhonghua Jiang; Hong Li; Mingyuan Li
Journal:  Virol J       Date:  2013-01-31       Impact factor: 4.099

10.  Molecular adjuvant Ag85A enhances protection against influenza A virus in mice following DNA vaccination.

Authors:  Jun Dai; Decui Pei; Baoning Wang; Yu Kuang; Laifeng Ren; Kang Cao; Huan Wang; Bin Zuo; Jingjing Shao; Sha Li; Hong Li; Mingyuan Li
Journal:  Viruses       Date:  2012-12-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.